BCR and chronic myelogenous leukemia, BCR-ABL1 positive: First, the initial intra-clonal heterogeneity of the CML clone and the existence of a specific profile of the immature CD34+ subpopulation [34,77] indicate that although BCR-ABL is expressed in all the cells of the clone, the DNA methylation alteration profile is different between immature and mature cells.